Physician profile
James G Hendricks
NPI 1710976055
$22,815.13
in general payments reported to CMS, 2019-2025
28 companies · $1,122 in 2025
The $1,122 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $467 · 2020: $201 · 2021: $472 · 2022: $547 · 2023: $4,041 · 2024: $16K · 2025: $1,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $15K · Travel and Lodging: $3,564 · Food and Beverage: $2,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $15,250.00 |
| Travel and Lodging | $3,564.32 |
| Food and Beverage | $2,313.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,233.81 | 2021-2024 | Davinci Xi |
| Procept Biorobotics Corporation | $915.70 | 2023 | Aquabeam Robotic System |
| Edap Technomed INC | $554.94 | 2025 | |
| Teleflex LLC | $468.23 | 2024 | Urolift |
| Boston Scientific Corporation | $407.28 | 2019-2025 | Ams 700 |
| Progenics Pharmaceuticals, INC. | $262.34 | 2022-2025 | |
| Janssen Biotech, INC. | $261.66 | 2019-2023 | Erleada |
| Abbvie INC. | $255.43 | 2019-2022 | |
| Pfizer INC. | $241.49 | 2019-2023 | |
| Laborie Medical Technologies Corp. | $172.54 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myovant Sciences INC. | $163.38 | 2021-2022 | |
| Astellas Pharma US INC | $149.18 | 2019-2023 | Xtandi |
| Calyxo, INC. | $137.67 | 2025 | Cvac Aspiration System |
| Bluewind Medical | $134.31 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $90.93 | 2019-2023 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $52.76 | 2022 | |
| Urogen Pharma, INC. | $41.51 | 2021-2023 | Jelmyto |
| Hollister Incorporated | $36.65 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $36.13 | 2022 | |
| Axonics, INC. | $29.39 | 2022 | |
| Dendreon Pharmaceuticals LLC | $26.89 | 2019 | |
| Bard Access Systems, INC. | $24.65 | 2019 | |
| Angiodynamics, INC. | $24.24 | 2021 | |
| Ferring Pharmaceuticals INC. | $23.44 | 2019 | |
| Biotissue Holdings INC. | $19.89 | 2022 | |
| Blue Earth Diagnostics | $18.01 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.51 | 2021 | |
| Coloplast Corp | $15.17 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.